Bejon P

Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.Abdel Hamid MM, Abdelraheem MH, Acheampong DO, Adam I, Aide P, Ajibaye O, Ali M, Almagro-Garcia J, Amambua-Ngwa A, Amenga-Etego L, Aniebo I, Aninagyei E, Ansah F, Apinjoh TO, Ariani CV, Auburn S, Awandare GA, Balmer A, Bejon P, Boene S, Bwire G, Candrinho B, Chidimatembue A, Chindavongsa K, Comiche K, Conway D, Dara A, Diakite M, Djimde A, Dondorp A, Doumbia S, Drury E, Fanello CA, Ferdig M, Figueroa K, Gamboa D, Golassa L, Gonçalves S, Guindo MDA, Hamaluba M, Hanboonkunupakarn B, Howe K, Hussien M, Imwong M, Ishengoma D, Jeans J, Kabaghe A, Kamuhabwa A, Kindermans JM, Konate DS, Kwiatkowski DP, Lee C, Lee SK, Lee SJ, Ley B, Llanos-Cuentas A, Marfurt J, Matambisso G, Maude RR, Maude RJ, Mayor A, Mayxay M, Maïga-Ascofaré O, McCann RS, Miles A, Miotto O, Mohamed AO, Morang'a CM, Murie K, Ngasala BE, Nguyen TN, Nolasco O, Nosten F, Noviyanti R, O'Connor Í Oboh M, Ochola-Oyier LI, Olufunke Falade C, Olukosi A, Olumide A, Olusola FI, Onyamboko MA, Oriero EC, Oyibo WA, Pannebaker D, Pearson RD, Phiri K, van der Pluijm RW, Price RN, Quang HH, Rajkumar Devaraju V, Randrianarivelojosia M, Ranford-Cartwright L, Rayner JC, Rovira-Vallbona E, Rowlands K, Ruano-Rubio V, Sanchez JF, Saúte F, Shettima S, da Silva C, Simpson VJ, Suddaby S, Takken W, Thu AM, Toure M, Unlu E, Valdivia HO, van Vugt M, Waithira N, Wellems T, Wendler J, White N, Wuendrich Ogidan R
Wellcome Open Res, (2025). 10:325

Serial cross-sectional school surveys identifies C469Y, P553L, R561H and A675V kelch 13 mutations associated with artemisinin resistance in Western Kenya.Osoti V, Wamae K, Musau MM, Magudha JB, Ndwiga L, Gichuki PM, Okoyo C, Rosebella K, Mahugu S, Aricha S, Kandie R, Keitany K, Kepha S, Mwandawiro C, Bejon P, Snow RW, Ochola-Oyier LI
Sci Rep, (2025). 15:38303

MALDI-TOF MS for malaria vector surveillance: A cost-comparison analysis using a decision-tree approach.Karisa J, Rist C, Tuwei M, Ominde K, Bartilol B, Ondieki Z, Musani H, Wanjiku C, Mwangangi J, Mbogo C, Rono M, Bejon P, Maia M
PLoS One, (2025). 20:e0335764

A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde RK, Gathuri H, Mwaniki P, Orindi B, Otieno EO, Mwakio S, Mulemi L, Isaaka L, Shangala J, Saisi M, Isinde E, Oginga IN, Wachira AW, Manuthu E, Kariuki H, Asaava P, Nyikuli J, Wekesa C, Otedo A, Bosire H, Okoth SB, Ongalo W, Mukabi DM, Lusamba W, Muthui B, Adembesa I, Mithi C, Sood M, Aliyan NA, Gituma B, Matiko MG, Omondi CA, Ombajo LA, Kirui N, Ochola L, Abdi AI, Kagucia EW, English M, Hamaluba M, Ochola-Oyier I, Kamuya D, Bejon P, Barasa E, Agweyu A, Akech S, Etyang AO
N Engl J Med, (2025). :

Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons.Ogwang R, Adan M, Bejon P, Kapulu MC
Front Immunol, (2025). 16:1672945

Assessing the Impact of SARS-CoV-2 Spike Mutations on Antibody Binding: A Comparative Assessment of the Wuhan and JN.1 Variants' Full-Length Spikes in a Multiplex Luminex Assay.Waweru G, Nyakundi R, Kutima B, Owuor S, Konyino G, Gitonga J, Lugano D, Maina A, Musyoki J, Ochola L, Omondi M, Kariuki CK, Ogongo P, Mwachari C, Shee F, Agoti C, Sande C, Uyoga S, Kagucia E, Agweyu A, Bejon P, Scott JAG, Warimwe GM, Ochola-Oyier LI, Nyagwange J
Viruses, (2025). 17:

Induction of an early IFN-γ cellular response and high plasma levels of SDF-1α are inversely associated with COVID-19 severity and residence in rural areas in Kenyan patients.Wanjiku P, Orindi B, Kimotho J, Sayed S, Shah R, Saleh M, Mwacharo J, Maronga C, Olouch V, Karanu A, Shah J, Nneka Z, Ochola-Oyier LI, Abdi AI, Dunachie S, Bejon P, Nduati EW, Ndungu FM
PLoS One, (2025). 20:e0316967

Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic wave.Lambisia AW, Katama EN, Moraa E, Mwita JM, Gallagher K, Mutunga M, Nyale E, Omungala J, Mwanga M, Murunga N, Nyiro J, Nyagwange J, Sande C, Bejon P, Githinji G, Dellicour S, Phan MVT, Cotten M, Ochola-Oyier LI, Holmes EC, Agoti CN
BMC Glob Public Health, (2025). 3:80

Making MALDI-TOF MS for entomological parameters accessible: A practical guide for in-house library creation.Karisa J, Tuwei M, Ominde K, Bartilol B, Ondieki Z, Musani H, Rono M, Mbogo C, Bejon P, Mwangangi J, Wanjiku C, Maia M
PLoS One, (2025). 20:e0330605

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.Kibwana E, Bundi C, Kimani D, Nyamako L, Keter K, Mutiso A, Ogwang R, Bellamy D, Rapi K, Bajer A, Provstgaard-Morys S, Stockdale L, Munoz O, Datoo MS, Lawrie A, Ramos-Lopez F, Roberts R, Hamaluba M, Hill AVS, Bejon P, Ewer KJ, Kapulu M
Front Immunol, (2025). 16:1620365

Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.Bundi C, Bellamy D, Kibwana E, Nyamako L, Ogwang R, Keter K, Kimani D, Salman AM, Provstgaard-Morys S, Stockdale L, Hill AVS, Bejon P, Olotu A, Hamaluba M, Ewer KJ, Kapulu MC
Front Immunol, (2025). 16:1620366

Emergence and transmission dynamics of the FY.4 Omicron variant in Kenya.Musundi S, Mwanga M, Lambisia A, Morobe JM, Murunga N, Moraa E, Ndwiga L, Cheruiyot R, Musyoki J, Mutunga M, Guzman-Rincon LM, Sande C, Mwangangi J, Bejon P, Ochola-Oyier LI, Nokes DJ, Agoti CN, Nyiro J, Githinji G
Virus Evol, (2025). 11:veaf035

OSBPL11 is an African-specific locus associated with 25-hydroxyvitamin D concentrations and cardiometabolic health.Mogire RM, Muriuki JM, Bayimenye RF, Mentzer AJ, Chong A, Gouveia MH, Bentley AR, Band G, King'ori P, Mitchell R, Webb EL, Sengupta D, Ekunwe L, Ndungu FM, Morovat A, Macharia AW, Cutland CL, Hemani G, Sirima SB, Ramsay M, Figueiredo CA, Prentice AM, Madhi SA, Raffield LM, Sandhu MS, Bejon P, Smith GD, Elliott AM, Williams TN, Rotimi C, Bourne CR, Burgett A, Adeyemo A, Atkinson SH
medRxiv, (2025). :

COVID-19 mortality in Africa and Asia - Authors' reply.Bejon P, Agweyu A, Oyier I, Hamaluba M, Kamuya D, Kinyanjui S, Barasa E
Lancet Infect Dis, (2025). :

Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to Shigella.Randall AZ, Conti V, Nakakana U, Liang X, Teng AA, Di Pasquale AL, Kapulu M, Frenck RJr, Launay O, Ferruzzi P, Sciré AS, Marchetti E, Obiero C, Pablo JV, Edgar J, Bejon P, Shandling AD, Campo JJ, Yee A, Martin LB, Podda A, Micoli F
mSphere, (2025). :e0105724

Rethinking the evidence on COVID-19 in Africa.Bejon P, Agweyu A, Ochola-Oyier LI, Hamaluba M, Kamuya D, Kinyanjui S, Barasa E
Lancet Infect Dis, (2025). 25:S1473-3099

Low-Dose Yellow Fever Vaccine in Adults in Africa.Kimathi D, Juan-Giner A, Bob NS, Orindi B, Namulwana ML, Diatta A, Cheruiyot S, Fall G, Dia M, Hamaluba MM, Nyehangane D, Karanja HK, Gitonga JN, Mugo D, Omuoyo DO, Hussein M, Oloo E, Kamau N, Wafula J, Bendera J, Silvester N, Mwavita J, Joshua M, Mwendwa J, Agababyona C, Ngetsa C, Aisha N, Moki F, Buluku T, Munene M, Mwanga-Amumpaire J, Lutwama J, Kayiwa J, Kamaara E, Barrett AD, Kaleebu P, Bejon P, Sall AA, Grais RF, Warimwe GM
N Engl J Med, (2025). 392:788-797

Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya.Osoti V, Wamae K, Ndwiga L, Gichuki PM, Okoyo C, Kepha S, Keitany K, Kandie R, Aricha S, Kiplagat R, Mwandawiro C, Bejon P, Snow RW, Ochola-Oyier LI
BMC Infect Dis, (2025). 25:73

Comparative performance of the InBios SCoV-2 Detect (TM) IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations.Kutima B, Kagucia EW, Mwai K, Kimani M, Sigilai A, Mugo D, Karanja H, Gitonga JN, Karani A, Akech D, Toroitich M, Karia B, Tuju J, Ziraba AK, Bigogo G, Ochieng C, Onyango C, Lidechi S, Munywoki PK, Uyoga S, Adetifa IMO, Oyier LIO, Bejon P, Scott JAG, Agweyu A, Warimwe GM, Nyagwange J
Wellcome Open Res, (2024). 9:349

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.Lugano D, Kutima B, Kimani M, Sigilai A, Gitonga J, Karani A, Akech D, Karia B, Ziraba AK, Maina A, Lambisia A, Omuoyo D, Mugo D, Lucinde R, Owuor S, Konyino G, Newman J, Bailey D, Nduati E, Githinji G, Agoti CN, Bejon P, Scott JAG, Agweyu A, Kagucia W, Warimwe GM, Sande C, Ochola-Oyier LI, Nyagwange J
BMC Infect Dis, (2024). 24:1474